Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
25.36
+0.47 (+1.89%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
34
35
Next >
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
↗
June 17, 2024
These high-flying stocks could have more room to run if analysts are right.
Via
The Motley Fool
2 Growth Stocks Wall Street Analysts Think Can Soar by at Least 80%
↗
June 15, 2024
There's a lot of hope for these stocks, but there's also a fair amount of risk.
Via
The Motley Fool
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It
↗
June 15, 2024
Just because a stock has amazing growth prospects doesn't mean you should ignore its valuation.
Via
The Motley Fool
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
↗
June 14, 2024
Novo Nordisk's competition in the obesity drug market is heating up.
Via
The Motley Fool
3 Stocks Under $10 Set to Quadruple by 2025: June Edition
↗
June 13, 2024
Low-priced stocks under $10 can be explosively awarding if you spot the right one at the right time with the right catalyst.
Via
InvestorPlace
Viking Therapeutics Unusual Options Activity For June 12
↗
June 12, 2024
Via
Benzinga
Looking At Viking Therapeutics's Recent Unusual Options Activity
↗
June 06, 2024
Via
Benzinga
What's Going On With Viking Therapeutics Stock On Tuesday?
↗
June 04, 2024
Viking Therapeutics reports promising 52-week data from its Phase 2b VOYAGE study on VK2809 for NASH.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
June 13, 2024
Via
Benzinga
3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years
↗
June 13, 2024
One of the best ways to spot winning stocks to buy is by spotting hot trends, such as artificial intelligence and obesity.
Via
InvestorPlace
Topics
Artificial Intelligence
3 Stocks Quietly Preparing for a 10X Surge: June Edition
↗
June 12, 2024
There are plenty of 10x stocks with the potential to surge 10x over. We’ve already seen in happen with Apple, Netflix, Microsoft and Nvidia.
Via
InvestorPlace
Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
↗
June 10, 2024
The company is focusing on obesity treatment after its glaucoma drug failed.
Via
Investor's Business Daily
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
↗
June 10, 2024
Success isn't guaranteed, but both companies could become big winners.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
↗
May 31, 2024
Via
Benzinga
This High-Flying Stock Just Announced More Good News: Time to Buy?
↗
June 09, 2024
The biotech's prospects keep getting brighter.
Via
The Motley Fool
Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor Enthusiasm
↗
June 08, 2024
You can use the wisdom of crowds and their fear and greed motives to profit from these three stocks to buy with plenty of room to run.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
↗
June 07, 2024
Via
Benzinga
Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
↗
June 07, 2024
The Nasdaq and S&P 500 hit record highs, but small caps retreated.
Via
Investor's Business Daily
Topics
Stocks
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
↗
June 06, 2024
These undervalued pharma stocks to buy are worth a look because even when the economy is struggling, consumers need key medicines.
Via
InvestorPlace
Topics
Economy
Is Viking Therapeutics Stock a Buy on the Dip?
↗
June 06, 2024
Short-term thinking is creating an intriguing opportunity for investors.
Via
The Motley Fool
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
↗
June 05, 2024
Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment....
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
June 04, 2024
Via
Benzinga
Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug
↗
June 04, 2024
Viking Therapeutics stock falls despite seemingly positive test results for a drug that treats a serious liver disease.
Via
Investor's Business Daily
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
↗
June 04, 2024
https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
↗
June 03, 2024
Via
Benzinga
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider
↗
June 03, 2024
Both of these companies could soon set the standard in their fields.
Via
The Motley Fool
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
↗
June 03, 2024
There's probably a big enough pie here for everyone to get a slice.
Via
The Motley Fool
Unearthing Unknown Stocks: 3 Picks That Could Be the Next Big Thing
↗
May 31, 2024
Sometimes the next big thing stocks to buy and hold are flying well under the radar. Here are three to consider.
Via
InvestorPlace
3 Underappreciated Stocks with Triple-Digit Upside: May 2024
↗
May 31, 2024
There are plenty of underappreciated stocks on the market. In fact, here are three you may want to consider buying and holding today.
Via
InvestorPlace
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
↗
May 29, 2024
Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.
Via
InvestorPlace
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
34
35
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
